by rss feed | Nov 29, 2016 | News Feeds
It may be possible to safely prevent one of the most common – and costly to treat – infections contracted by hospitalized patients undergoing bone marrow transplantation for the treatment of blood cancers, according to a study from the Abramson Cancer...
by admin | Nov 29, 2016 | Stem Cell News
View photos Https%3a%2f%2fblueprint-api-production.s3.amazonaws.com%2fuploads%2fstory%2fthumbnail%2f29389%2fskingun-clean More RenovaCare is awaiting FDA approval for a product they say can help burn victims regenerate their skin in days. Its “SkinGun”...
by rss feed | Nov 26, 2016 | News Feeds
Abstract The clinical effectiveness of systemically administered human mesenchymal stem cells (hMSCs) depends on their capacity to engage vascular endothelium. hMSCs derived from bone marrow (BM-hMSCs) natively lack endothelial binding capacity, but express a CD44...
by rss feed | Nov 26, 2016 | News Feeds
Abstract The clinical effectiveness of systemically-administered human mesenchymal stem cells (hMSCs) depends on their capacity to engage vascular endothelium. hMSCs derived from bone marrow (BM-hMSCs) natively lack endothelial binding capacity but express a CD44...
by rss feed | Nov 26, 2016 | News Feeds
Abstract Several experimental studies have provided evidence that bone-marrow derived mesenchymal stem (stromal) cells (MSC) may be effective in treating critically ill surgical patients who develop traumatic brain injury, acute renal failure, or the acute respiratory...
